MedTrace Logo

Assessment of Serum Levels of Adenosine Deaminase and Immunoglobulin E in Patients With Chronic Spontaneous Urticaria

NCT05992987 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2023-08-15

No results posted yet for this study

Summary

adenosine deaminase activity (ADA) has been reported to be elevated in various diseases such as psoriasis, acne and juvenile idiopathic arthritis. There is no previous studies that assessed ADA in chronic spontaneous urticaria (CSU) .

Conditions

Interventions

DIAGNOSTIC_TEST

Adenosine deaminase serum level

Adenosine deaminase will be measured by enzymatic (clorometric / kinetic) method (Diazyme laboratories, San Diego, California, USA).

DIAGNOSTIC_TEST

IgE antibodies serum level

Level of IgE will be measured by electrochemiluminesence immunoassay (ECLIA, automatic cobase immunoassay, Roche Diagnostics GmbH, Mannheim, USA).

Sponsors & Collaborators

  • Sohag University

    lead OTHER

Principal Investigators

  • Ramadan Saleh, MD · Sohag University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-15
Primary Completion
2023-12-31
Completion
2024-03-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05992987 on ClinicalTrials.gov